Pseudocholinesterase deficiency is a rare clinical condition primarily associated with genetic alterations, but it can also be caused by certain diseases and medication factors. Patients with this condition experience significantly prolonged muscle paralysis when succinylcholine or mivacurium is used during general anesthesia, due to the decreased enzyme levels. The diagnosis of pseudocholinesterase deficiency is typically made after the administration of succinylcholine or mivacurium. Inquiring about the patient's family history is also crucial for proper diagnosis and intervention. Here, we report a case of a rare pseudocholinesterase deficiency patient who experienced delayed recovery following general anesthesia for flexible bronchoscopy. The patient was a healthy 67-year-old male with no history of liver or kidney dysfunction or other diseases. The plan was to perform painless flexible bronchoscopy, and after the procedure, the patient exhibited delayed recovery. Throughout the process, electrocardiographic monitoring showed normal blood pressure, heart rate, and oxygen saturation. After ruling out other factors that could cause delayed emergence, including central nervous system issues and electrolyte imbalances, it was found that succinylcholine, a depolarizing muscle relaxant, had been used. There was a high suspicion of pseudocholinesterase deficiency in the patient. Pseudocholinesterase enzyme activity testing was performed, and the patient was continued on mechanical ventilatory support. After 220 minutes from the completion of the procedure, the patient regained spontaneous breathing and full consciousness, and the endotracheal tube was removed. This article presents a case of delayed recovery in a patient with pseudocholinesterase deficiency following painless flexible bronchoscopy. It also summarizes the causes, clinical manifestations, diagnosis, and treatment of pseudocholinesterase deficiency-related delayed emergence. It is hoped that this article will contribute to timely recognition and management of such cases, thereby preventing any potential adverse outcomes for patients. Furthermore, since pseudocholinesterase deficiency is relatively rare, further research is needed to confirm the effectiveness of the preventive and therapeutic measures mentioned in this article.
Published in | International Journal of Anesthesia and Clinical Medicine (Volume 11, Issue 2) |
DOI | 10.11648/j.ijacm.20231102.13 |
Page(s) | 69-71 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Pseudocholinesterase Deficiency, Delayed Recovery, Succinyl Choline
[1] | Andersson ML, Møller AM, Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review. Anaesthesia. 2019 Apr; 74 (4): 518-528. |
[2] | Zhang C, Cao H, Wan ZG, Wang J. Prolonged neuromuscular block associated with cholinesterase deficiency. Medicine (Baltimore). 2018 Dec; 97 (52): e13714. |
[3] | Lee S, Han JW, Kim ES. Butyrylcholinesterase deficiency identified by preoperative patient interview. Korean J Anesthesiol. 2013 Dec; 65 (6 Suppl): S1-3. |
[4] | Reti IM, Torres J, Morad A, et al. Pseudocholinesterase deficiency in an ECT patient: a case report. Psychosomatics 2011; 52: 392–3. 10.1016/j.psym.2011.01.029. |
[5] | Tran DTT, Newton EK, Mount VAH, et al.. Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review. Anaesthesia. 2017; 72: 765–777. |
[6] | Pühringer FK, Rex C, Sielenkämper AW, et al.. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008; 109: 188–197. |
[7] | Alvarellos ML, McDonagh EM, Patel S, McLeod HL, Altman RB, Klein TE. PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics. 2015 Dec; 25 (12): 622-30. |
[8] | Robles A, Michael M, McCallum R. Pseudocholinesterase Deficiency: What the Proceduralist Needs to Know. Am J Med Sci. 2019 Mar; 357 (3): 263-267. |
[9] | Blitt CD, Petty WC, Alberternst EE, et al.. Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy. Anesth Analg 1977; 56: 78–83. 10.1213/00000539-197701000-00019. |
[10] | Soliday FK, Conley YP, Henker R. Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences. Aana J 2010; 78: 313–20. |
[11] | Chan JM. Drug Metabolism and Pharmacogenetics. In: Hemmings HC, Egan D, editors. Pharmacology and Physiology for Anesthesia 2nd ed. Philadelphia, Pa: Elsevier; 2019. pp. 70–90. |
[12] | Gätke MR, Bundgaard JR, Viby-Mogensen J. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia. Pharmacogenet Genomics. 2007; 17: 995–999. |
[13] | Yildizhan E, Tomruk NB, Aytac HM, et al. Severe pseudocholinesterase deficiency and ECT: a case report. Dusunen Adam 2018; 31: 312–5. 10.5350/DAJPN2018310311. |
[14] | Hawkins J, Khanna S, Argalious M. Sugammadex for reversal of neuromuscular blockade: uses and limitations. Curr Pharm Des. 2019; 25: 2140–2148. |
[15] | Lakshmi N Kurnutala, Nickhil Rugnath2. Pseudocholinesterase Deficiency – Is Succinylcholine Still Needed to Facilitate Endotracheal Intubation?Cureus. 2020 Sep; 12 (9): e10721. |
[16] | Klucka J, Kosinova M, Zacharowski K, et al. Rapid sequence induction: an international survey. Eur J Anaesthesiol. 2020; 37: 435–442. |
[17] | Delacour H, Dedome E, Courcelle S, Hary B, Ceppa F. Butyrylcholinesterase deficiency. Deficit Genetique en Butyrylcholinesterase. 2016; 74: 279–85. |
APA Style
Dongjiao Wu, Xuejie Li. (2023). A Case of Pseudocholinesterase Deficiency in Patient Underwent General Anesthesia with Flexible Bronchoscopy. International Journal of Anesthesia and Clinical Medicine, 11(2), 69-71. https://doi.org/10.11648/j.ijacm.20231102.13
ACS Style
Dongjiao Wu; Xuejie Li. A Case of Pseudocholinesterase Deficiency in Patient Underwent General Anesthesia with Flexible Bronchoscopy. Int. J. Anesth. Clin. Med. 2023, 11(2), 69-71. doi: 10.11648/j.ijacm.20231102.13
AMA Style
Dongjiao Wu, Xuejie Li. A Case of Pseudocholinesterase Deficiency in Patient Underwent General Anesthesia with Flexible Bronchoscopy. Int J Anesth Clin Med. 2023;11(2):69-71. doi: 10.11648/j.ijacm.20231102.13
@article{10.11648/j.ijacm.20231102.13, author = {Dongjiao Wu and Xuejie Li}, title = {A Case of Pseudocholinesterase Deficiency in Patient Underwent General Anesthesia with Flexible Bronchoscopy}, journal = {International Journal of Anesthesia and Clinical Medicine}, volume = {11}, number = {2}, pages = {69-71}, doi = {10.11648/j.ijacm.20231102.13}, url = {https://doi.org/10.11648/j.ijacm.20231102.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijacm.20231102.13}, abstract = {Pseudocholinesterase deficiency is a rare clinical condition primarily associated with genetic alterations, but it can also be caused by certain diseases and medication factors. Patients with this condition experience significantly prolonged muscle paralysis when succinylcholine or mivacurium is used during general anesthesia, due to the decreased enzyme levels. The diagnosis of pseudocholinesterase deficiency is typically made after the administration of succinylcholine or mivacurium. Inquiring about the patient's family history is also crucial for proper diagnosis and intervention. Here, we report a case of a rare pseudocholinesterase deficiency patient who experienced delayed recovery following general anesthesia for flexible bronchoscopy. The patient was a healthy 67-year-old male with no history of liver or kidney dysfunction or other diseases. The plan was to perform painless flexible bronchoscopy, and after the procedure, the patient exhibited delayed recovery. Throughout the process, electrocardiographic monitoring showed normal blood pressure, heart rate, and oxygen saturation. After ruling out other factors that could cause delayed emergence, including central nervous system issues and electrolyte imbalances, it was found that succinylcholine, a depolarizing muscle relaxant, had been used. There was a high suspicion of pseudocholinesterase deficiency in the patient. Pseudocholinesterase enzyme activity testing was performed, and the patient was continued on mechanical ventilatory support. After 220 minutes from the completion of the procedure, the patient regained spontaneous breathing and full consciousness, and the endotracheal tube was removed. This article presents a case of delayed recovery in a patient with pseudocholinesterase deficiency following painless flexible bronchoscopy. It also summarizes the causes, clinical manifestations, diagnosis, and treatment of pseudocholinesterase deficiency-related delayed emergence. It is hoped that this article will contribute to timely recognition and management of such cases, thereby preventing any potential adverse outcomes for patients. Furthermore, since pseudocholinesterase deficiency is relatively rare, further research is needed to confirm the effectiveness of the preventive and therapeutic measures mentioned in this article.}, year = {2023} }
TY - JOUR T1 - A Case of Pseudocholinesterase Deficiency in Patient Underwent General Anesthesia with Flexible Bronchoscopy AU - Dongjiao Wu AU - Xuejie Li Y1 - 2023/07/31 PY - 2023 N1 - https://doi.org/10.11648/j.ijacm.20231102.13 DO - 10.11648/j.ijacm.20231102.13 T2 - International Journal of Anesthesia and Clinical Medicine JF - International Journal of Anesthesia and Clinical Medicine JO - International Journal of Anesthesia and Clinical Medicine SP - 69 EP - 71 PB - Science Publishing Group SN - 2997-2698 UR - https://doi.org/10.11648/j.ijacm.20231102.13 AB - Pseudocholinesterase deficiency is a rare clinical condition primarily associated with genetic alterations, but it can also be caused by certain diseases and medication factors. Patients with this condition experience significantly prolonged muscle paralysis when succinylcholine or mivacurium is used during general anesthesia, due to the decreased enzyme levels. The diagnosis of pseudocholinesterase deficiency is typically made after the administration of succinylcholine or mivacurium. Inquiring about the patient's family history is also crucial for proper diagnosis and intervention. Here, we report a case of a rare pseudocholinesterase deficiency patient who experienced delayed recovery following general anesthesia for flexible bronchoscopy. The patient was a healthy 67-year-old male with no history of liver or kidney dysfunction or other diseases. The plan was to perform painless flexible bronchoscopy, and after the procedure, the patient exhibited delayed recovery. Throughout the process, electrocardiographic monitoring showed normal blood pressure, heart rate, and oxygen saturation. After ruling out other factors that could cause delayed emergence, including central nervous system issues and electrolyte imbalances, it was found that succinylcholine, a depolarizing muscle relaxant, had been used. There was a high suspicion of pseudocholinesterase deficiency in the patient. Pseudocholinesterase enzyme activity testing was performed, and the patient was continued on mechanical ventilatory support. After 220 minutes from the completion of the procedure, the patient regained spontaneous breathing and full consciousness, and the endotracheal tube was removed. This article presents a case of delayed recovery in a patient with pseudocholinesterase deficiency following painless flexible bronchoscopy. It also summarizes the causes, clinical manifestations, diagnosis, and treatment of pseudocholinesterase deficiency-related delayed emergence. It is hoped that this article will contribute to timely recognition and management of such cases, thereby preventing any potential adverse outcomes for patients. Furthermore, since pseudocholinesterase deficiency is relatively rare, further research is needed to confirm the effectiveness of the preventive and therapeutic measures mentioned in this article. VL - 11 IS - 2 ER -